focus on the sichuan and chongqing sectors丨qinchuan iot and zhifei biotech ranked first in weekly gains
2024-09-30
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
on september 27, 2024, upstream news reporters sorted out the one-week stock price increases and decreases of sichuan and chongqing a-share listed companies.
flush data shows that of 77 chongqing a-share stocks, 76 closed up and 1 closed down.
among the stocks leading the gains, zhifei biotech, chongqing department store, and shanwaishan rose 34.33%, 25.21%, and 23.71% respectively, ranking among the top three a-share gains in chongqing.
there were 175 sichuan a-share companies, of which 173 closed up, 1 closed flat, and 1 closed down.
among the stocks leading the gains, qinchuan wulian, luzhou laojiao, and wuliangye increased by 54.22%, 34.25%, and 33.96% respectively, ranking among the top three sichuan a-share gains.
34.33%! zhifei biotechnology ranks first among chongqing stocks
zhifei biotechnology’s stock price is 27.82 yuan, with a stock price increase of 34.33% this week, ranking first among chongqing a-share listed companies in terms of weekly increase.
in the first half of 2024, zhifei biotech achieved operating income of 18.258 billion yuan, a year-on-year decrease of 25.31%; net profit attributable to the parent company was 2.234 billion yuan, a year-on-year decrease of 47.55%; net profit after non-profit deductions was 2.230 billion yuan, a year-on-year decrease of 47.04%; basic earnings per share were 0.9322 yuan.
niu yang, an investment consultant at hualong securities, believes that as china's leading private vaccine stock, zhifei biotech is a component stock of the csi 300 index and the gem index. according to the latest policies of the china securities regulatory commission, major index constituent stocks will have mandatory market value management. zhifei biotech it is undoubtedly a good thing to formulate and disclose the market value management system of listed companies after review by the board of directors.
zhifei biotechnology has clear plans for independent products, and is continuing to actively promote the promotion and sales of independent products on sale, striving to make existing products bring greater performance contribution to the company.
it is worth looking forward to the approval of products such as the quadrivalent influenza vaccine that has been reported for production, the human diploid vaccine that has completed clinical trials, the 15-valent pneumonia conjugate vaccine in phase iii, and the quadrivalent meningococcal conjugate vaccine.
in addition, zhifei biotech is actively promoting the clinical progress of innovative varieties. currently, there are 31 non-covid-19 projects under research, 14 of which are in the clinical stage.
chongqing department store’s stock price is 23.04 yuan, with a stock price increase of 25.21% this week, ranking second in chongqing stock’s weekly stock price increase, with a year-to-date increase of -14.17%.
chongqing department store announced that in the first half of 2024, it achieved operating income of 8.979 billion yuan, a decrease of 11.56% from the same period last year; net profit attributable to the parent company was 711 million yuan, a decrease of 21.06% from the same period; net profit after non-discounting was 705 million yuan, a decrease from the same period last year. a decrease of 12.92% over the same period; basic earnings per share was 1.63 yuan.
shanwaishan’s stock price is 9.65 yuan, with a stock price increase of 23.71% this week, ranking third among the chongqing listed companies’ stock prices for a weekly increase. shanwaishan's main business is specializing in the research and development, production and sales of blood purification equipment and consumables, and providing chain hemodialysis medical services.
in addition, one of the chongqing stocks that closed down this week was st huicheng, with a weekly decline of -8.40%.
54.22%! qinchuan iot ranked first among sichuan stocks in weekly gains
qinchuan wulian's stock price is 10.41 yuan, with a stock price increase of 54.22% this week. the stock price of listed companies in sichuan has the highest weekly increase, with a year-to-date increase of -5.79%.
the full name of qinchuan iot is chengdu qinchuan iot technology co., ltd. it is a high-tech enterprise engaged in theoretical research and standard research on the internet of things and smart cities and the development, manufacturing, sales and service of its products. it is committed to the smart city internet of things. , industrial internet of things and smart sensor business, the actual controller is shao zehua.
qinchuan wulian achieved operating income of 189 million yuan in the first half of 2024, an increase of 42.12% over the same period last year; net profit attributable to the parent company was -19.65 million yuan, and net profit attributable to the parent company after deduction was -20.74 million yuan; basic earnings per share -0.12 yuan.
on the news, on september 26, qinchuan wulian (688528) announced that the company is planning a major asset reorganization and plans to acquire 60% of the equity of chengdu pivot technology co., ltd., a company to be listed, in cash.
luzhou laojiao’s stock price is 136.09 yuan, an increase of 34.25% this week, ranking second in the weekly increase in stock prices of sichuan a-share listed companies, and a year-to-date increase of -21.79%.
the full name of luzhou laojiao co., ltd. is luzhou laojiao co., ltd. luzhou laojiao achieved operating income of 16.904 billion yuan in the first half of 2024, an increase of 15.84% over the same period last year; net profit attributable to the parent company was 8.027 billion yuan, an increase of 13.22% over the same period; excluding non-profit net profit attributable to the parent company was 7.994 billion yuan, an increase of 13.54% over the same period; basic earnings per share was 5.46 yuan.
wuliangye's stock price is 147.74 yuan, with a stock price increase of 33.96% this week. it ranks third among sichuan stocks with a weekly increase of 8.92% year-to-date.
wuliangye achieved operating income of 50.648 billion yuan in the first half of 2024, a year-on-year increase of 11.30%; net profit attributable to the parent company was 19.056 billion yuan, a year-on-year increase of 11.86%; net profit after non-profit deductions was 18.938 billion yuan, a year-on-year increase of 11.79%; basic the profit per share was 4.91 yuan.
xiao zhuqing, an independent critic of china's liquor industry, believes that although the liquor industry is in cyclical fluctuations, the performance of leading liquor companies in the first half of the year has generally been good, which has injected strong confidence into the market. wuliangye and luzhou laojiao are both listed in the csi 300 the performance of index constituent stocks in the first half of the year has maintained steady growth and is in an oversold state. they are important targets for mandatory market value management and are also favored by funds.
in addition, one sichuan stock that closed flat was st shengda. the stock that ended lower was sirnaomics, with a weekly loss of -4.07%.
upstream news reporter liu yong interns liang siqi
